Semagacestat (LY450139)

Catalog No.S1594

Semagacestat (LY450139) Chemical Structure

Molecular Weight(MW): 361.44

Semagacestat (LY450139) is a γ-secretase blocker for Aβ42, Aβ40 and Aβ38 with IC50 of 10.9 nM, 12.1 nM and 12.0 nM, also inhibits Notch signaling with IC50 of 14.1 nM in H4 human glioma cell. Phase 3.

Size Price Stock Quantity  
In DMSO USD 190 In stock
USD 170 In stock
USD 320 In stock
USD 970 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

3 Customer Reviews

  • HEK/APPswe cells were either left non-treated (-) or exposed to the γ-secretase inhibitor (GSI) semagacestat (+) for 19 h prior to cell harvesting and membrane preparation (Substrate accumulation). Exposure of cells with GSI prior to membrane preparation results in higher Aβ1-42 and Aβx-42 signals as compared to membranes derived from non-GSI treated cells. Direct addition of semagacestat to the membranes in the novo Aβ production assay inhibited Aβ production (Semagacestat (1 µM)). The amount of Aβx-42 is higher than Aβ1-42 suggesting that C83 is the major substrate for the Aβ42 signal detected.

    J Biol Chem 2014 289(3), 1540-50. Semagacestat (LY450139) purchased from Selleck.

    None of the AZ GSMs (square, triangle, and ×) or E2012 (O) affect Notch processing, whereas the GSIs L685458, DBZ, MRK-560, and Semagacestat do, as measured by quantifying the amount of nuclearly trans- located NICD in HEK293 cells stably transfected with △ENotch using immunocytochemistry. % NICD translocation is set relative to 0.5% DMSO (100%) and 0.5 μM L685458(0%)controls(mean±S.E., n=2).

    J Biol Chem 2012 287(15), 11810-9. Semagacestat (LY450139) purchased from Selleck.

  • Cultures were assessed in A for TRAP by enzyme histochemistry 5-8 days following exposure to Rankl. Values are means ± S.D.; n = 6 for all data sets except for Notch2Q2319X DMSO at day 5 where n = 5; the right upper panel shows representative culture fields of TRAP-stained multinucleated cells 8 days after the addition of Rankl.

    J Biol Chem, 2016, 291(4):1538-51.. Semagacestat (LY450139) purchased from Selleck.

Purity & Quality Control

Choose Selective Gamma-secretase Inhibitors

Biological Activity

Description Semagacestat (LY450139) is a γ-secretase blocker for Aβ42, Aβ40 and Aβ38 with IC50 of 10.9 nM, 12.1 nM and 12.0 nM, also inhibits Notch signaling with IC50 of 14.1 nM in H4 human glioma cell. Phase 3.
Features The best characterized γ-secretase inhibitor that has reached the clinic.
γ secretase(Aβ42) [1]
(H4 human glioma cells)
γ secretase(Aβ38) [1]
(H4 human glioma cells)
γ secretase(Aβ40) [1]
(H4 human glioma cells)
Notch [1]
(H4 human glioma cells)
10.9 nM 12.0 nM 12.1 nM 14.1 nM
In vitro

Semagacestat reduces the secretion of Aβ42, Aβ40 and Aβ38 from H4 human glioma cells stably overexpressing human wild-type APP into the culture medium, with IC50 of 10.9 nM, 12.1 nM and 12.0 nM, respectively, without affecting cell viability. Semagacestat also increases β-CTF in cell lysates with ECmax of 16.0 nM, and the increase can be unexpectedly attenuated at high concentrations. Semagacestat inhibits Notch signaling with IC50 of 14.1 nM, and shows minimal Notch-sparing selectivity with Notch IC50/Aβ42 IC50 only 1.3. [1] Semagacestat causes a concentration-dependent decrease in Aβ40 secreted into the medium with IC50 of 111 nM from murine CTX expressing endogenous murine APP, but murine Aβ42 formation in CTX is roughly 12-fold less than Aβ40 in accordance with data for neurons from wild type mice. [2]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
CHO cells NYP6doxzTnWwY4Tpc44h[XO|YYm= Moq5TY5pcWKrdHnvckBw\iCpYX3tZU1{\WO{ZYThd4UhcW5iQ1jPJINmdGy|IHHzd4V{e2WmIHX4dJJme3OrbnegRXBRW3diYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCjbYnsc4llKGKndHGoNUB1dyC6KTDz[YNz\XSrb36gZYZ1\XJib4\ldo5q\2i2IHnuZ5Vj[XSrb36gZpkhTUyLU1GsJGVFPTB;MD6wNVUh|ryP MlTSNlM4OTN4NU[=
human SH-SY5Y cells MkXsSpVv[3Srb36gZZN{[Xl? MYXJcohq[mm2aX;uJI9nKGejbX3hJJNm[3KndHHz[U1u\WSrYYTl[EBidXmub3nkJIJmfGFiKEGgeI8hPDBrIIDyc4R2[3Srb36gbY4hcHWvYX6gV2guW1l3WTDj[YxteyxiSVO1NF0xNjB|ODFOwG0> M3HlfVE6Pjl2NE[3
African green monkey CV1 cells M2OwXGZ2dmO2aX;uJIF{e2G7 Mnr5TY5pcWKrdHnvckBw\iCpYX3tZU1{\WO{ZYThd4Uh\XiycnXzd4VlKGmwIHHmdolk[W5iZ4Ll[Y4hdW:wa3X5JGNXOSClZXzsd{Bkd2W6cILld5NqdmdiR3HsOEBFVkFvYnnu[Ilv\y:2cnHud4FkfGm4YYTpc44h\G:vYXnuJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gco91[2hicILvZ4V{e2mwZzDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGG|c3H5MEBKSzVyPUCuN|E3OjNizszN NXf4bG9ZOjByNU[1OFE>

... Click to View More Cell Line Experimental Data

In vivo Oral administration of Semagacestat (1 mg/kg) to 5.5-month old APP-transgenic Tg2576 mice significantly ameliorates memory deficits on spatial working memory using the Y-maze task, which disappears after 8 days subchronic dosing. LY450139 decreases hippocampal levels of both Aβ42 and Aβ40 at 10 mg/kg (22-23% reduction) and 30 mg/kg (36-41% reduction) and increases β-CTF at 0.3-10 mg/kg in a dose dependent manner with no inhibition on the processing of other γ-secretase substrates, such as Notch, N-cadherin or EphA4, in the brain, but impairs normal cognition in wild-type mice and 3-month-old Tg2576 mice failing to restore cognitive deficits in the Y-maze test. [1]


Kinase Assay:[1]
+ Expand

Cellular APP processing assay and Notch signaling assay:

H4 human glioma cells stably overexpressing human wild-type APP695 are treated with Semagacestat at various concentrations for 24 hours. Levels of Aβ42, Aβ40, and Aβ38 in the media are measured using separate ELISA kits. The expression vector of the constitutively active form of Notch (NotchΔE), encoding bases 1-60 and 5193-6657 of the human Notch1 coding region (NM_017617), is constructed into a pcDNA3.1 vector with a sequence modification from mouse to human. Notch signaling activity is evaluated using Cignal RBP-Jk Reporter Assay kit. RBP-Jk protein [CSL/CBF1/Su(H)/Lag1] is a transcription factor activated with Notch intracellular domain produced by γ-secretase. H4 cells are transiently transfected with the human NotchΔE expression vector and the RBP-Jk-responsive luciferase construct using Lipofectamine 2000, and then exposed to various concentrations of Semagacestat for 16 hours. Notch signaling is measured based on luciferase activity in the cell lysate using the Dual-Glo Luciferase Assay System.
Cell Research:[2]
+ Expand
  • Cell lines: Murine cortical neurons and cerebellar granule cells
  • Concentrations: Dissolved in DMSO, final concentration ~10 μM
  • Incubation Time: 24 hours
  • Method: Cells are incubated with Semagacestat for 24 hours. For detection of cell viability, the percentage of viable cells is quantified by their capacity to reduce 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) following incubation with 0.5 mg/mL MTT for 60 minutes. For the detection of sAPP species, cells are lysed and analysed by western blotting.
    (Only for Reference)
Animal Research:[1]
+ Expand
  • Animal Models: Female Tg2576 mice expressing human APP695 with the Swedish mutation (K670N/M671L)
  • Formulation: Dissolved in 0.5% methyl cellulose.
  • Dosages: ~30 mg/kg
  • Administration: Orally administered once daily
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 72 mg/mL (199.2 mM)
Ethanol 41 mg/mL (113.43 mM)
Water slightly soluble or insoluble
In vivo Add solvents individually and in order:
0.5% methylcellulose
30 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 361.44


CAS No. 425386-60-3
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01035138 Completed Alzheimers Disease Eli Lilly and Company December 2009 Phase 3
NCT00762411 Completed Alzheimers Disease Eli Lilly and Company September 2008 Phase 3
NCT00594568 Completed Alzheimers Disease Eli Lilly and Company March 2008 Phase 3
NCT00765115 Completed Alzheimer Disease Eli Lilly and Company July 2006 Phase 1
NCT00244322 Completed Alzheimers Disease Eli Lilly and Company October 2005 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Gamma-secretase Signaling Pathway Map

Gamma-secretase Inhibitors with Unique Features

Related Gamma-secretase Products

Tags: buy Semagacestat (LY450139) | Semagacestat (LY450139) supplier | purchase Semagacestat (LY450139) | Semagacestat (LY450139) cost | Semagacestat (LY450139) manufacturer | order Semagacestat (LY450139) | Semagacestat (LY450139) distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID